skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors 

Protease Inhibitors 

Entry Inhibitors 

Integrase Inhibitors 

Antiretroviral Pregnancy Registry 

Back to Top